2 completed, 1 suspended, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Suspended 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow RFB4(dsFv)-PE38 recombinant immunotoxin: new trials by email Literature Review of RFB4(dsFv)-PE38 recombinant immunotoxin trials Research Report on RFB4(dsFv)-PE38 recombinant immunotoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia BL22 (CAT-3888) - Hairy Cell Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 1 | 2009-02-01 | 2015-10-29 |
| BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy - Leukemia, Lymphoma | Phase 1 | Completed | MedImmune LLC | 24 | 2005-06-01 | 2010-06-22 |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy - Leukemia, Lymphoma | Phase 1 | Suspended | MedImmune LLC | 95 | 2004-01-01 | 2007-12-28 |
| Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia BL22 immunotoxin - Leukemia | Phase 1 | Completed | National Cancer Institute (NCI) | 1998-12-01 | 2015-04-29 | |
| BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia BL22 immunotoxin, antibody therapy, biological response modifier therapy - Leukemia, Lymphoma | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2015-04-28 |
Leukemia (5) · Lymphoma (3) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Prolymphocytic (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Waldenstrom Macroglobulinemia (1)
National Cancer Institute (NCI) (3) · MedImmune LLC (2)
United States (5)
Robert Kreitman, MD (3) · Alan S. Wayne, MD (1) · Robert J Kreitman, M.D. (1)